P338: effectiveness and safety of biological therapies in elderly inflammatory bowel diseases patients results from a multi center study of GeteccuECCO'21 VirtualYear: 2021
Authors: Suarez Ferrer, C.J.(1);Mesonero , F.(2);Caballol, B.(3);Saiz Chumillas, R.(4);Bastón-Rey, I.(5);Rubin de Celix, C.(6);Melcarne, L.(7);Caballero Mateos, A.(8);Calafat, M.(9);Alonso Galan, H.(10);Vega Villaamil, P.(11);Castro Senosiain, B.(12);Rodriguez Diaz, C.Y.(13);Plaza Santos, R.(14);Marques Cami, M.(15);Rodriguez Grau, M.C.(16);Ramirez, F.(17);Lopez-García, A.(18);Gomez Pastrana, B.(19);Gonzalez Partida, I.(20);Botella Mateu, B.(21);Cuevas del Campo, L.(22);Gonzalez Peña, E.(23);Iyo, E.(24);Elosua Gonzalez, A.(25);Sainz, E.(26);Hernandez, L.(27);Perez Galindo, P.(28);Rueda Garcia, J.L.(29);Martin-Arranz, M.D.(29);Lopez Sanroman, A.(30);Fernandez-Clotet, A.(3);Sicilia, B.(4);Calviño Suárez, C.(5);Mañosa Ciria, M.(9);Barreiro-De Acosta, M.(5);
(1)Hospital Universitario La Paz, GASTROENTEROLOGY DEPARTMENT, Madrid, Spain;(2)Ramón y Cajal University Hospital. Madrid, Gastroenterology Department-, Madrid, Spain;(3)Hospital Clinic of Barcelona, Gastroenterology department, Barcelona, Spain;(4)Burgos University Hospital, Gastroenterology department, Burgos, Spain;(5)Hospital Universitario Clínico de Santiago, Gastroenterology department, Santiago de compostela, Spain;(6)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP., Gastroenterology deparment, Madrid, Spain;(7)Hospital Universitari Parc Taulli, Gastroenterology Department, Sabadel- Barcelona, Spain;(8)Hospital Clinico San Cecilio, Gastroenterology department, Granada, Spain;(9)Hospital Germans Trias i Pujol, Gastroenterology department, Badalona, Spain;(10)Hospital Comarcal de Guipuzcua, Gastroenterology Department, Donostia, Spain;(11)Complexo Hospitalario Universitario de Ourense, Gastroenterology department, Ourense, Spain;(12)Hospital Universitario Marqués de Valdecilla. IDIVAL, Gastroenterology Department, Santander, Spain;(13)Hospital Universitario Nuestra Señora de la Candelaria, Gastroenterology Department, Tenerife, Spain;(14)Infanta Leonor University Hospital, Gastroenterology department, Madrid, Spain;(15)Hospital Arnau de Vilanova, Gastroenterology Department, Lleida, Spain;(16)Hospital del Henares, Gastroenterology Department, Coslada- Madrid, Spain;(17)Ciudad Real University Hospital, Gastroenterology Department, Ciudad Real, Spain;(18)Hospital del Mar, Gastroenterology Department, Barcelona, Spain;(19)General Hospital of Mataro, Gastroenterology Department, Maresme-Barcelona, Spain;(20)Hospital Universitario puerta de hierro, Gastroenterology department, Majadahonda-Madrid, Spain;(21)Hospital Univesitario Infanta Cristina, Gastroenterology department, Parla-Madrid, Spain;(22)Getafe University Hospital, Gastroenterology department, Getafe-Madrid, Spain;(23)Hospital Royo Villanova, Gastroenterology department, Zaragoza, Spain;(24)Hospital Comarcal de Inca, Gastroenterology Department, Baleares, Spain;(25)Hospital Garcia Orcoyen, Gastroenterology department, Estella-Navarra, Spain;(26)Hospital Xara Assistencial Althaia de Manressa, Gastroenterology Department, Barcelona, Spain;(27)Hospital Santos Reyes, Gastroenterology department, Aranda del duero-Burgos, Spain;(28)Pontevedra University Hospital Complex, Gastroenterology department, Pontevedra, Spain;(29)School of Medicine. Universidad Autónoma de Madrid. Hospital La Paz Institute forHealth Research- La Paz Hospita, Gastroenterology Department, Madrid, Spain;(30)Ramón y Cajal University Hospital, Gastroenterology deparment, Madrid, Spain; On behalf of the young GETECCU group
P339: Pregnant women with perianal Crohn’s Disease: suggestions for the improvement of the current guideline on delivery methodECCO'21 VirtualYear: 2021
Authors: Schaafsma, I.(1);Hoogenboom, F.(2);Visschedijk, M.(1);Prins, J.(3);Dijkstra, G.(1);
(1)University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(2)University Medical Center Groningen, Department of Surgery, Groningen, The Netherlands;(3)University Medical Center Groningen, Department of Gynecology, Groningen, The Netherlands
P340: Real-world treatment patterns and recurrence rates of rectovaginal fistulas in patients with Crohn’s disease: A retrospective cohort database analysisECCO'21 VirtualYear: 2021
Authors: Karki, C.(1);Latremouille-Viau, D.(2);Gilaberte, I.(3);Hantsbarger, G.(4);Romdhani, H.(2);Lightner, A.(5);
(1)Takeda Pharmaceuticals USA- Inc., Global Evidence and Outcomes, Cambridge, United States;(2)Analysis Group- Inc., Analysis Group, Montreal, Canada;(3)Takeda Pharmaceuticals USA- Inc., Clinical Sciences, Cambridge, United States;(4)Takeda Pharmaceuticals USA- Inc., Statistical and Quantitative Sciences, Cambridge, United States;(5)Cleveland Clinic, Department of Colon and Rectal Surgery, Cleveland, United States
P340: Risankizumab in Inflammatory Bowel Disease: Real World Experience from a Pre-Approval Access ProgramECCO'22Year: 2021
Authors: Dawson, P.(1);Sharma, E.(1);Dart, R.J.(1);Lim, S.(1);Anderson, S.H.(1);Ray, S.(1);Mawdsley, J.(1);Irving, P.M.(1);Samaan, M.A.(1);
(1)Guys and St Thomas NHS trust, Department of Gastroenterology, London, United Kingdom;
P341: Perceived risks and psychosocial burden during the COVID-19 pandemic in a large cohort of pediatric and adult patients with Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Koletzko, L.(1);Klucker, E.(2);Le Thi, G.(2);Breiteneicher, S.(1);Rubio-Acero, R.(3);Neuhaus, L.(1);Stark, R.(4);Standl, M.(5);Hölscher, M.(3);Török, H.(1);Koletzko, S.(2,6);Schwerd, T.(2);
(1)LMU Klinikum, Department of Medicine II, Munich, Germany;(2)LMU Klinikum, Department of Pediatrics- Dr von Hauner Kinderspital, Munich, Germany;(3)LMU Klinikum, Division of Infectious Diseases and Tropical Medicine, Munich, Germany;(4)Helmholtz Zentrum München, Institute of Health Economics and Healthcare Management, Neuherberg, Germany;(5)Helmholtz Zentrum München, Institute of Epidemiology, Neuherberg, Germany;(6)University of Warmia and Mazury, Department of Pediatrics- Gastroenterology and Nutrition- School of Medicine Collegium Medicum, Olsztyn, Poland
P342: Correlation of the first lateral flow-based Point of Care test to quantify infliximab and anti-infliximab antibodies in a finger prick sample with the reference ELISA techniqueECCO'21 VirtualYear: 2021
Authors: Ruiz-Argüello, M.B.(1);Pascual, J.(1);Del Río, L.(1);Urigoitia, A.(1);Balo Farto, C.(2);Fernández, C.(3);Mera, A.(2);De Toro, J.(3);Nagore, D.(1);Ametzazurra, A.(1);
(1)Progenika Biopharma - Grifols, Department of R&D, Derio, Spain;(2)Hospital Clínico Universitario de Santiago, Servicio Reumatología, Santiago de Compostela, Spain;(3)Complexo Hospitalario Universitario A Coruña, Servicio Reumatología, A Coruña, Spain
P343: Maintenance of deep remission in Crohn’s disease after switching from anti–TNF to ustekinumab.ECCO'21 VirtualYear: 2021
Authors: Mantzaris, G.(1);Vraka, M.(1);Beka, H.(1);Georgiadi, T.(1);Albani, F.(1);Veretanos, C.(1);Mountaki, K.(1);Trikola, A.(1);Archavlis, E.(1);Christidou, A.(1);Manolakis, A.(1);Viazis, N.(1);Karampekos, G.(1);Philippidis, G.(1);Hatzievangelinou, C.(1);Tsatsa, A.(1);Georgiadou, A.(1);Panagopoulou, S.(1);
(1)Evaggelismos GHA, Gastroenterology, Athens, Greece
P344: Effectiveness and safety of switching patients with inflammatory bowel disease from originator infliximab to CT-P13: systematic review and meta-analysisECCO'21 VirtualYear: 2021
Authors: Hanzel, J.(1,2);Strik, A.(2);Gecse, K.(2);D'Haens, G.(2);Dreesen, E.(3,4);
(1)University Medical Centre Ljubiljana, Department of Gastroenterology, Ljubljana, Slovenia;(2)Amsterdam UMC- AMC, Department of Gastroenterology, Amsterdam, The Netherlands;(3)KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium;(4)Uppsala University, Department of Pharmacy, Uppsala, Sweden
P345: Food-related quality of life in adults with Inflammatory Bowel Disease is influenced by restrictive eating behaviour, disease activity and surgery: a prospective multi-centre studyECCO'21 VirtualYear: 2021
Authors: Day, A.(1,2);Yao, C.K.(3);Costello, S.(2,4);Andrews, J.(2,5);Bryant, R.(1,2);
(1)The Queen Elizabeth Hospital- Central Adelaide Local Health Network, Gastroenterology & Hepatology, Adelaide, Australia;(2)University of Adelaide, School of Medicine- Faculty of Health Sciences, Adelaide, Australia;(3)Monash University & Alfred Hospital, Translational Nutritional Sciences- Gastroenterology, Melbourne, Australia;(4)The Queen Elizabeth Hospital- Central Adelaide Local Health Network- School of Medicine- Faculty of Health Sciences- University of Adelaide, Gastroenterology & Hepatology, Adelaide, Australia;(5)Royal Adelaide Hospital- Central Adelaide Local Health Network, Gastroenterology & Hepatology, Adelaide, Australia
P346: Decreasing disparities in and use of systemic corticosteroid and disparities in use among paediatric patients with Crohn disease in a multicentre collaborativeECCO'21 VirtualYear: 2021
Authors: Adler, J.(1);Kandavel, P.(2);Eder, S.(1);Saeed, S.(3);
(1)University of Michigan, Susan B. Meister Child Health Evaluation and Research Center, Ann Arbor, United States;(2)Children's Hospital of Los Angeles, Pediatric Gastroenterology, Los Angeles, United States;(3)Dayton Children's Hospital, Pediatric Gastroenterology, Dayton, United States; ImproveCareNow Network
P347: Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseasesECCO'21 VirtualYear: 2021
Authors: Attauabi , M.(1,2,3);Höglund , C.(4);Fassov , J.(5);Pedersen , K.B.(6);Bansholm Hansen , H.(7);Wildt , S.(8);Dam Jensen , M.(9);Neumann , A.(10);Lind , C.(10);Albæk Jacobsen , H.(11);Popa , A.M.(12);Kjeldsen , J.(13);Pedersen , N.(14);Molazahi , A.(15);Haderselv , K.(16);Aalykke , C.(4);Knudsen , T.(6);Cebula , W.(12);Munkholm, P.(7);Bendtsen , F.(1,2);Seidelin , J.B.(3);Johan , B.(1,2);
(1)Copenhagen University Hospital, Gastrounit- Medical Section, Hvidovre, Denmark;(2)University of Copenhagen- Hvidovre Hospital, Copenhagen center for inflammatory bowel disease in children- adolescents and adults, Hvidovre, Denmark;(3)Herlev Hospital- University of Copenhagen, Department of Gastroenterology and Hepatology, Herlev, Denmark;(4)OUH Svendborg Hospital, Department of Medicine- Section of Gastroenterology, Svendborg, Denmark;(5)Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark;(6)Hospital of South West Denmark, Department of Medical Gastroenterology, Esbjerg, Denmark;(7)North Zealand University Hospital, Department of Gastroenterology, Frederikssund, Denmark;(8)Zealand University Hospital, Department of Medicine- Division of Gastroenterology, Koege, Denmark;(9)Lillebaelt Hospital, Department of Internal Medicine- Section of Gastroenterology, Vejle, Denmark;(10)Regional Hospital Viborg, Department of Internal Medicine, Viborg, Denmark;(11)Aalborg University Hospital, Department of Gastroenterology and Hepatology, Aalborg, Denmark;(12)Nykoebing Falster Hospital, Department of Medicine, Nykoebing Falster, Denmark;(13)OUH Odense University Hospital, Department of Medical Gastroenterology S, Odense, Denmark;(14)Slagelse Hospital, Department of Gastroenterology, Slagelse, Denmark;(15)Holbaek Hospital, Department of Internal Medicine, Holbaek, Denmark;(16)Rigshospitalet- Copenhagen University Hospital, Department of Gastroenterology, Copenhagen, Denmark
P348: Perception of cancer risk in inflammatory bowel disease-associated dysplasia and management practice is influenced by colonoscopy experience and workplace affiliation: results of an international clinician surveyECCO'21 VirtualYear: 2021
Authors: Kabir, M.(1,2);Thomas-Gibson, S.(1,2);Hart, A.(2,3);Wilson, A.(1,2);
(1)St Mark's Hospital, Wolfson Endoscopy Unit, London, United Kingdom;(2)Imperial College London, Division of Surgery and Cancer, London, United Kingdom;(3)St Mark's Hospital, IBD Unit, London, United Kingdom
P351: SARS-CoV-2 infection and seroconversion in pediatric patients on biological therapy for Crohn’s disease: single tertiary center experienceECCO'21 VirtualYear: 2021
Authors: Sładek, M.(1); Krucka-Kawalec , M.(2);Wojtas, E.(2);Jagielski , P.(3);Stochel-Gaudyn, A.(1);
(1)Jagiellonian University Medical College, Department of Pediatrics- Gastroenterology and Nutrition, Krakow, Poland;(2)University Children's Hospital in Krakow, Department of Pediatrics- Gastroenterology and Nutrition, Krakow, Poland;(3)Faculty of Health Science- Jagiellonian University Medical College- Cracow- Poland, Department of Nutrition and Drug Research-, Kraków, Poland
P352: A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn’s disease. The Cross Pennine study IIECCO'21 VirtualYear: 2021
Authors: Lenti, M.V.(1,2);Dolby, V.(1);Clark, T.(1);Hall, V.(1);Tattersall, S.(1);Fairhurst, F.(1);Kenneth, C.(1);Walker, R.(1);Kemp, K.(1);Borg-Bartolo, S.(1);Limdi, J.(1);Taylor, J.(1);Townsend, T.(1);Subramanian, S.(1);Storey, D.(1);Assadsangabi, A.(1);Stansfield, C.(1);Smith, P.(1);Byrne, D.(1);De Silvestri, A.(1,3);Selinger, C.(1);
(1)Cross Pennine IBD study group- Leeds W Yorkshire- United Kingdom, Gastroenterology, Leeds, United Kingdom;(2)San Matteo Hospital Foundation- University of Pavia- Italy, Internal Medicine, Pavia, Italy;(3)San Matteo Hospital Foundation- University of Pavia- Italy, Epidemiology and Biostatistics, Pavia, Italy
P353: Pan-enteric capsule endoscopy enables assessment of mucosal healing after biologic treatment initiation in Crohn’s diseaseECCO'21 VirtualYear: 2021
Authors: Volkers, A.(1);Bosuyt, P.(2);de Jong, J.(1);D'Haens, G.(1);Löwenberg, M.(1);
(1)Amsterdam UMC- location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands;(2)Imeldaziekenhuis, Gastroenterology and Hepatology, Bonheiden, Belgium
P354: Early treatment versus active surveillance after ileocolic resection in Crohn’s disease: a retrospective cohort study.ECCO'21 VirtualYear: 2021
Authors: Haenen, S.(1);Sabino, J.(1);Bislenghi, G.(2);D'Hoore, A.(2);Ferrante, M.(1);Vermeire, S.(1);
(1)University hospitals Leuven, Department of Gastroenterology, Leuven, Belgium;(2)University hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium
P355: Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL studyECCO'21 VirtualYear: 2021
Authors: Taxonera Samso, C.(1);Martínez-Montiel, P.(2);Barreiro-De-Acosta, M.(3);Vera, I.(4);Lorente, R.(5);Vega, P.(6);Diz-Lois, M.T.(7);Fuentes Coronel, A.M.(8);Pérez Calle, J.L.(9);Casis, B.(2);Ferreiro, R.(3);Calvo, M.(4);Olivares, D.(1);Alba, C.(1);
(1)Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain;(2)Hospital Universitario 12 de Octubre, Gastroenterology, Madrid, Spain;(3)Hospital Universitario Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain;(4)Hospital Universitario Puerta de Hierro Majadahonda, Gastroenterology, Madrid, Spain;(5)Hospital General Universitario de Ciudad Real, Gastroenterology, Ciudad Real, Spain;(6)Complexo Hospitalario Universitario de Ourense, Gastroenterology, Ourense, Spain;(7)Hospital Universitario de A Coruña, Gastroenterology, A Coruña, Spain;(8)Hospital Virgen de la Concha, Gastroenterology, Zamora, Spain;(9)Hospital Universitario Fundacion Alcorcon, Gastroenterology, Madrid, Spain
